drugset / Trial / NCT01839721

Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation

NCT01839721

Phase 3 Completed 246 enrolled CHU de Quebec-Universite Laval
RandomizedParallel-groupTriple-blindPrevention

Summary

In this double-blinded randomized clinical trial study, investigators assessed probiotic used to prevent or delay radiation induced grade moderate to severe diarrhea with patient treated for pelvic cancer.

Timeline

Start
2006-12
Primary completion
2010-11
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Probiotics Other / unclassified 1.3e+09 unknown
Comparator Probiotics Other / unclassified 1e+10 unknown